Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE ε4 carriers: A case-control study

BMJ Open

Volumn 3, Issue 9, 2013, Pages

  Fernández Martínez, Manuel ^a   Martín, Xabier Elcoroaristizabal ^b   Martín, Elisa Blanco ^a   Alcelay, Luis Galdos ^c   Serrano, Iratxe Ugarriza ^a   Busto, Fernando Gómez ^d   Álvarez Álvarez, Maite ^b   Salazar, Ana Molano ^a   Gandarias, Rocio Bereincua ^a   Borda, Sandra Inglés ^c   Valiente, Juan María Uterga ^e   Juanbeltz, Begoña Indakoetxea ^f   Beldarraín, María Ángeles Gómez ^g   López, Josefa Moraza ^c   Amillano, Myriam Barandiarán ^f   De Pancorbo, Marian M ^b  

^a BIOCRUCES BIZKAIA HEALTH RESEARCH INSTITUTE   (Spain)

^b BIOMICS Research Group   (Spain)

^c HOSPITAL TXAGORRITXU   (Spain)

^d Basque Country Cancer Registry   (Spain)

^e HOSPITAL DE BASURTO   (Spain)

^f HOSPITAL DONOSTIA   (Spain)

^g HOSPITAL DE GALDAKAO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; ALZHEIMER DISEASE; ARTICLE; DIAGNOSIS RELATED GROUP; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84885337237     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003200     Document Type: Article

References (67)

1. Bertram L, McQueen MB, Mullin K, et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007;39:17-23. (Pubitemid 46026496)
2. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72. (Pubitemid 23230526)
3. Carrasquillo MM, Belbin O, Hunter TA, et al. Replication of CLU, CR1, and PICALM associations with alzheimer disease. Arch Neurol 67:961-4.
4. Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009;41:1088-93.
5. Lambert JC, Heath S, Even G, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009;41:1094-9.
6. Seshadri S, Fitzpatrick AL, Ikram MA, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010;303:1832-40.
7. Garcia-Segura LM, McCarthy MM. Minireview: role of glia in neuroendocrine function. Endocrinology 2004;145:1082-6. (Pubitemid 38280986)
8. Hu R, Cai WQ, Wu XG, et al. Astrocyte-derived estrogen enhances synapse formation and synaptic transmission between cultured neonatal rat cortical neurons. Neuroscience 2007;144:1229-40. (Pubitemid 46123793)
9. Marin R, Guerra B, Alonso R, et al. Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection. Curr Neurovasc Res 2005;2:287-301. (Pubitemid 41297367)
10. Hao J, Janssen WG, Tang Y, et al. Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J Comp Neurol 2003;465:540-50. (Pubitemid 37193697)
11. Woolley CS, McEwen BS. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 1992;12:2549-54.
12. Pike CJ, Carroll JC, Rosario ER, et al. Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol 2009;30:239-58.
13. Amtul Z, Wang L, Westaway D, et al. Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease. Neuroscience 169(2):781-6.
14. Janicki SC, Schupf N. Hormonal influences on cognition and risk for Alzheimer's disease. Curr Neurol Neurosci Rep 10(5):359-66.
15. Seshadri S, Fitzpatrick AL, Ikram MA, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303:1832-40.
16. Holland D, Desikan RS, Dale AM, et al. Higher Rates of Decline for Women and Apolipoprotein E ε4 Carriers. AJNR Am J Neuroradio. 2013 Jul 4. [Epub ahead of print]. doi: 10.3174/ajnr.A3601
17. Callahan MJ, Lipinski WJ, Bian F, et al. Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am J Pathol 2001;158:1173-7. (Pubitemid 32221809)
18. Wang J, Tanila H, Puolivali J, et al. Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice. Neurobiol Dis 2003;14:318-27. (Pubitemid 37543511)
19. Baldereschi M, Di Carlo A, Lepore V, et al. Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology 1998;50:996-1002. (Pubitemid 28212828)
20. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-32. (Pubitemid 26267873)
21. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology 1997;48: 1517-21.
22. Resnick SM, Metter EJ, Zonderman AB. Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect? Neurology 1997;49:1491-7. (Pubitemid 28015106)
23. Hogervorst E, Bandelow S. Brain and cognition. Is there any case for improving cognitive function in menopausal women using estrogen treatment? Minerva Ginecol 2009;61:499-515.
24. Maki PM, Sundermann E. Hormone therapy and cognitive function. Hum Reprod Update 2009;15:667-81.
25. Henderson VW. Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause. J Steroid Biochem Mol Biol. 2013 May 28. pii: S0960-0760(13) 00081-2 doi:10.1016/j.jsbmb.2013.05.010 [Epub ahead of print].
26. Nathan BP, Barsukova AG, Shen F, et al. Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons. Endocrinology 2004;145:3065-73. (Pubitemid 38829971)
27. Shughrue P, Scrimo P, Lane M, et al. The distribution of estrogen receptor-beta mRNA in forebrain regions of the estrogen receptor-alpha knockout mouse. Endocrinology 1997;138: 5649-52. (Pubitemid 27509733)
28. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-alpha and-beta mRNA in the rat central nervous system. J Comp Neurol 1997;388:507-25. (Pubitemid 27481288)
29. Castagnoli A, Maestri I, Bernardi F, et al. PvuII RFLP inside the human estrogen receptor gene. Nucleic Acids Res 1987;15:866.
30. Yaffe K, Lui LY, Grady D, et al. Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women. Biol Psychiatry 2002;51:677-82. (Pubitemid 34310505)
31. Maruyama H, Toji H, Harrington CR, et al. Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer disease. Arch Neurol 2000;57:236-40. (Pubitemid 30097192)
32. Brandi ML, Becherini L, Gennari L, et al. Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease. Biochem Biophys Res Commun 1999;265:335-8.
33. Isoe-Wada K, Maeda M, Yong J, et al. Positive association between an estrogen receptor gene polymorphism and Parkinson's disease with dementia. Eur J Neurol 1999;6:431-5. (Pubitemid 29371139)
34. Mattila KM, Axelman K, Rinne JO, et al. Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women. Neurosci Lett 2000;282:45-8. (Pubitemid 30129165)
35. Pavao M, Traish AM. Estrogen receptor antibodies: specificity and utility in detection, localization and analyses of estrogen receptor alpha and beta. Steroids 2001;66:1-16.
36. Weickert CS, Miranda-Angulo AL, Wong J, et al. Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet 2008;17:2293-309.
37. Pirskanen M, Hiltunen M, Mannermaa A, et al. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women. Eur J Hum Genet 2005;13:1000-6. (Pubitemid 43073605)
38. Westberg L, Hakansson A, Melke J, et al. Association between the estrogen receptor beta gene and age of onset of Parkinson's disease. Psychoneuroendocrinology 2004;29:993-8. (Pubitemid 38833525)
39. Dresner-Pollak R, Kinnar T, Friedlander Y, et al. Estrogen receptor beta gene variant is associated with vascular dementia in elderly women. Genet Test Mol Biomarkers 2009;13:339-42.
40. Petersen RC. Mild cognitive impairment clinical trials. Nat Rev Drug Discov 2003;2:646-53. (Pubitemid 37361768)
41. Wilton S, Lim L. Rapid identification of ApoE alleles by multiple-single-strand conformation polymorphism (SSCP) analysis. Trends Genet 1995;11:341.
42. Alvarez-Alvarez M, Galdos L, Fernandez-Martinez M, et al. 5-Hydroxytryptamine 6 receptor (5-HT(6)) receptor and apolipoprotein E (ApoE) polymorphisms in patients with Alzheimer's disease in the Basque Country. Neurosci Lett 2003;339:85-7. (Pubitemid 36263226)
43. Rousset F. genepop'007: a complete re-implementation of the genepop software for Windows and Linux. Mol Ecol Resources 2008;8:103-6. (Pubitemid 350231212)
44. Corbo RM, Gambina G, Ruggeri M, et al. Association of estrogen receptor alpha (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer's disease and their effect on apolipoprotein E concentrations. Dement Geriatr Cogn Disord 2006;22:67-72.
45. Monastero R, Cefalu AB, Camarda C, et al. Association of estrogen receptor alpha gene with Alzheimer's disease: a case-control study. J Alzheimers Dis 2006;9:273-8. (Pubitemid 44253345)
46. Porrello E, Monti MC, Sinforiani E, et al. Estrogen receptor alpha and APOEepsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females. Eur J Neurol 2006;13:639-44. (Pubitemid 43873637)
47. Den Heijer T, Schuit SC, Pols HA, et al. Variations in estrogen receptor alpha gene and risk of dementia, and brain volumes on MRI. Mol Psychiatry 2004;9:1129-35. (Pubitemid 40065458)
48. Lambert JC, Harris JM, Mann D, et al. Are the estrogen receptors involved in Alzheimer's disease? Neurosci Lett 2001;306:193-7. (Pubitemid 32530832)
49. Prince JA, Feuk L, Sawyer SL, et al. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur J Hum Genet 2001;9:437-44. (Pubitemid 32577180)
50. Usui C, Shibata N, Ohnuma T, et al. No genetic association between the myeloperoxidase gene-463 polymorphism and estrogen receptor-alpha gene polymorphisms and Japanese sporadic Alzheimer's disease. Dement Geriatr Cogn Disord 2006;21:296-9. (Pubitemid 43735673)
51. Luckhaus C, Sand PG. Estrogen Receptor 1 gene (ESR1) variants in Alzheimer's disease. Results of a meta-analysis. Aging Clin Exp Res 2007;19:165-8. (Pubitemid 46779402)
52. Rodriguez E, Mateo I, Llorca J, et al. No association between low density lipoprotein receptor genetic variants and Alzheimer's disease risk. Am J Med Genet B Neuropsychiatr Genet 2006;141B:541-3. (Pubitemid 44024450)
53. Boada M, Antunez C, Lopez-Arrieta J, et al. Estrogen receptor alpha gene variants are associated with Alzheimer's disease. Neurobiol Aging 2012;33:198.e15-24.
54. Ji Y, Urakami K, Wada-Isoe K, et al. Estrogen receptor gene polymorphisms in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia. Dement Geriatr Cogn Disord 2000;11:119-22. (Pubitemid 30216203)
55. Lin GF, Ma QW, Zhang DS, et al. Polymorphism of alpha-estrogen receptor and aryl hydrocarbon receptor genes in dementia patients in Shanghai suburb. Acta Pharmacol Sin 2003;24:651-6.
56. Long JR, Xu H, Zhao LJ, et al. The oestrogen receptor alpha gene is linked and/or associated with age of menarche in different ethnic groups. J Med Genet 2005;42:796-800. (Pubitemid 41475258)
57. Forsell C, Enmark E, Axelman K, et al. Investigations of a CA repeat in the oestrogen receptor beta gene in patients with Alzheimer's disease. Eur J Hum Genet 2001;9:802-4. (Pubitemid 33019169)
58. Goumidi L, Dahlman-Wright K, Tapia-Paez I, et al. Study of estrogen receptor-α and receptor-β gene polymorphisms on Alzheimer's disease. Alzheimers Dis 2011;26:431-9.
59. 2 toxicity in human neuroblastoma SK-N-SH cells. Mol Pharmacol 2006;70:395-404.
60. Ishunina TA, Van Heerikhuize JJ, Ravid R, et al. Estrogen receptors and metabolic activity in the human tuberomamillary nucleus: changes in relation to sex, aging and Alzheimer's disease. Brain Res 2003;988:84-96. (Pubitemid 37289497)
61. Chace C, Pang D, Weng C, et al. Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome. J Alzheimers Dis 2012;28:601-12.
62. Birge SJ. The role of estrogen in the treatment of Alzheimer's disease. Neurology 1997;48(5 Suppl):S36-41. (Pubitemid 27230091)
63. Stone DJ, Rozovsky I, Morgan TE, et al. Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease. J Neurosci 1998;18:3180-5. (Pubitemid 28186010)
64. Toran-Allerand CD, Miranda RC, Bentham WD, et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 1992;89:4668-72.
65. Gandy S. Estrogen and neurodegeneration. Neurochem Res 2003;28:1003-8. (Pubitemid 36581850)
66. Raber J. AR, apoE, and cognitive function. Hormones Behav 2008;53:706-15.
67. Lund TD, Hinds LR, Handa RJ. The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus. J Neurosci 2006;26:1448-56. (Pubitemid 43237015)